dermatomycosis

(redirected from Dermatomycoses)
Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

dermatomycosis

 [der″mah-to-mi-ko´sis]
a superficial fungal infection of the skin or of its appendages.

der·ma·to·my·co·sis

(der'mă-tō-mī-kō'sis),
Fungus infection of the skin caused by dermatophytes, yeasts, and other fungi. Compare: dermatophytosis.

dermatomycosis

/der·ma·to·my·co·sis/ (der″mah-to-mi-ko´sis) a superficial fungal infection of the skin or its appendages.

dermatomycosis

[dur′mətō′mīkō′sis]
Etymology: Gk, derma + mykes, fungus, osis, condition
a superficial fungal infection of the skin, characteristically found on parts that are moist and protected by clothing, such as the groin or feet. It is caused by a dermatophyte. See also dermatophytosis. dermatomycotic, adj.

dermatomycosis

A fungal skin infection

der·ma·to·my·co·sis

(dĕr'mă-tō-mī-kō'sis)
Fungus infection of the skin caused by dermatophytes, yeasts, and other fungi.
Compare: dermatophytosis

dermatophytosis

inflammation of skin, nails and hair follicles due to dermatophyte infection, causing erythema, itching, papular vesiculation, interdigital and heel fissures and skin scaling; superficial infections are common in adults, especially those with dyshidrosis, living in community, using communal sports or bathing facilities, diabetics or those on long-term antibiotic or immunosuppressive therapies (see onychomycosis; tinea pedis; Table 1)
Table 1: Treatment of fungal infections of skin and nails
Infection siteAgent
Antimycotic agent (for the treatment of dermatophytosis)
SkinTopical allylamine (e.g. 1% terbinafine cream for 7 days)
Topical imidazoles (e.g. 2% miconazole or 1% clotrimazole for 28 days)
Topical 0.25% amorolfine
Topical 1% econazole
Topical griseofulvin spray (400 μg puff daily for 14 days)
Topical 1% sulconazole
Topical tea tree (manuka) oil
Topical undecenoate (20% zinc undecenoate + 5% undecenoic acid)
Topical Whitfield's ointment (6% benzoic acid + 3% salicylic acid)
Other topicals include: weak iodine solution 2.5%; potassium permanganate paint 1%; salicylate acid cream or alcoholic solution 3-5%; benzoic acid (Whitfield's) ointment; sodium polymetaphosphate dusting powder
Systemic terbinafine (250 mg daily for 2 weeks)
Systemic itraconazole (100 mg daily for 15 days)
Systemic griseofulvin (500 mg daily )
NailTopical amorolfine 0.25% lacquer as an adjunct to systemic treatment
Topical borotannic acid complex acid; Phytex paint (1.46% salicylic acid + 4.89% tannic acid + 3.12% boric acid)
Topical 28% tioconazole lacquer
Topical undecenoate lacquer; Monphytol paint (5% methyl undecenoate + 0.7% propyl undecenoate + 3% salicylic acid + 25% methyl salicylate + 5% propyl salicylate + 3% chlorambucil)
Other topicals: strong iodine 10% solution
Systemic terbinafine (250 mg daily for 12-16 weeks)
Systemic itraconazole (400 mg for 1 week in a month, repeated overall 3 or 4 times)
Anticandidal agent (for the treatment of candidiasis)
SkinTopical antimycotic creams (1% clotrimazole; 1% econazole; 2% miconazole)
Topical nystatin (100 000 units ± 1% tolnaftate)
Antipityriasis versicolor agent (for the treatment of pityriasis versicolor)
SkinTopical 2% ketoconazole
Topical 2.5% selenium sulphide
Topical antimycotic agents (1% clotrimazole; 1% econazole; 2% miconazole; 1% sulconazole; 1% terbinafine)
Systemic fluconazole/itraconazole/ketoconazole/miconazole/voriconazole

dermatomycosis

a fungal infection of the skin or of its appendages by a fungus other than the dermatophytes, Microsporum, Trichophyton or Epidermophyton.
References in periodicals archive ?
The severity of foot dermatomycoses was rated on a scale of 0 (none) to 3 (severe disease).
In all, having any foot dermatomycoses was associated with an odds ratio of 2.
A snapshot of the global therapeutic scenario for Dermatomycoses.
treated for dermatomycoses in Phase II and Phase III clinical trials in Japan